Preferential cytotoxicity of cells transduced with cytosine deaminase compared to bystander cells after treatment with 5-flucytosine

Cancer Research

Volumn 58, Issue 12, 1998, Pages 2588-2593

  Lawrence, Theodore S ^a,c   Rehemtulla, Alnawaz ^a   Ng, Emily Y ^a   Wilson, Melinda ^b   Trosko, James E ^b   Stetson, Philip L ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOSINE DEAMINASE; FLUCYTOSINE; FLUOROURACIL;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; GAP JUNCTION; GENE THERAPY; GENETIC TRANSDUCTION; LIVER CELL; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; CELL SURVIVAL; CYTOSINE DEAMINASE; FLUCYTOSINE; GAP JUNCTIONS; GENE THERAPY; HUMANS; NUCLEOSIDE DEAMINASES; PRODRUGS; RATS; TUMOR CELLS, CULTURED;

EID: 0032526178     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Connors, T. A. The choice of prodrugs for gene directed enzyme prodrug therapy of cancer. Gene Ther., 2: 702-709, 1995.
2. Moolten, F. L. Drug sensitivity ("suicide") genes for selective cancer chemotherapy. Cancer Gene Ther., 1: 279-287, 1994.
3. Deonarain, M. P., Spooner, R. A., and Epenetos, A. A. Genetic delivery of enzymes for cancer therapy. Gene Ther., 2: 235-244, 1995.
4. Khil, M. S., Kim, J. H., Mullen, C. A., Kim, S. H., and Freytag, S. O. Radiosensitization by 5-fluorocytosine of human colorectal carcinoma cells in culture transduced with cytosine deaminase gene. Clin. Cancer Res., 2: 53-57, 1996.
5. Hoganson, D. K., Batra, R. K., Olsen, J. C., and Boucher, R. C. Comparison of the effects of three different toxin genes and their levels of expression on cell growth and bystander effect in lung adenocarcinoma. Cancer Res., 56: 1315-1323, 1996.
6. Trinh, Q. T., Austin, E. A., Murray, D. M., Knick, V. C., and Huber, B. E. Enzyme/prodrug gene therapy: Comparison of cytosine deaminase/5-fluorocytosine versus thymidine kinase/ganciclovir enzyme/prodrug systems in a human colorectal carcinoma cell line. Cancer Res., 55: 4808-4812, 1995.
7. Hooper, M. L., and Subak-Sharpe, J. H. Metabolic cooperation between cells. Int. Rev. Cytol., 69: 45-104, 1981.
8. Trosko, J. W., Madhukar, B. V., and Chang, C. C. Endogenous and exogenous modulation of gap junctional intercellular communication: toxicological and pharmacological implications. Life Sci., 53: 1-19, 1993.
9. Pitts, J. D. Cancer gene therapy: a bystander effect using the gap junctional pathway. Mol. Carcinog., 11: 127-130, 1994.
10. Fick, J., Barker, F. G., Dazin, P., Westphale, E. M., Beyer, E. C., and Israel, M. A. The extent of heterocellular communication mediated by gap junctions is predictive of bystander tumor cytotoxicity in vitro. Proc. Natl. Acad. Sci., 92: 11071-11075, 1995.
11. Wygoda, M. R., Wilson, M., Davis, M. A., Trosko, J. E., Rehemtulla, A., and Lawrence, T. S. Protection of HSV-TK-transduced cells from ganciclovir-mediated cytotoxicity by bystander cells: the Good Samaritan effect Cancer Res., 57: 1699-1703, 1997.
12. Holder, J. W., Elmore, E., and Barrett, J. C. Gap junction function and cancer. Cancer Res., 53: 3475-3485, 1993.
13. Ram, Z., Culver, K. W., Walbridge, S., Blaese, R. M., and Oldfield, E. H. In situ retroviral-mediated gene transfer for the treatment of brain tumors in rats. Cancer Res., 53: 83-88, 1993.
14. Loewenstein, W. R., and Rose, B. The cell-cell channel in the control of growth. Semin. Cell Biol., 3: 59-79, 1992.
15. Hotz-Wagenblatt, A., and Shalloway, D. Gap junctional communication and neoplastic transformation. Oncogenesis, 4: 541-558, 1993.
16. Oh, S. Y., Dupont, E., Madhukar, B. V., Briand, J. P., Chang, C. C., Beyer, E., and Trosko, J. E. Characterization of gap junctional communication-deficient mutants of a rat liver epithelial cell line. Eur. J. Cell Biol., 60: 250-255, 1993.
17. Austin, E. A., and Huber, B. E. A first step in the development of gene therapy for colorectal carcinoma: cloning, sequencing, and expression of Escherichia coli cytosine deaminase. Mol. Pharmacol., 43: 380-387, 1993.
18. Kalimi, G. H., Hampton, L., Trosko, J., Thorgeirsson, S., and Huggett, A. Homologous and heterologous gap-junctional intercellular communication in v-raf-, v-myc-, and v-raf/v-myc-transduced rat liver epithelial cell lines. Mol Carcinog., 5: 301-310, 1992.
19. Loch-Caruso, R., Pahl, M. S., and Juberg, D. J. Rat myometrial smooth muscle cells show high levels of gap junctional communication under a variety of culture conditions. In Vitro Cell. Dev. Biol., 28A: 97-101, 1992.
20. Lawrence, T. S., Davis, M. A., Maybaum, J., Mukhopadhay, S. K., Stetson, P. L., Normolle, D. P., McKeever, P. E., and Ensminger, W. D. The potential superiority of bromodeoxyuridine to iododeoxyuridine as a radiation sensitizer in the treatment of colorectal cancer. Cancer Res., 52: 3698-3704, 1992.
21. Freeman, S. M., Abboud, C. N., Whartenby, K. A., Packman, C. H., Koeplin, D. S., Moolten, F. L., and Abraham, G. N. The "bystander effect": tumor regression when a fraction of the tumor mass is genetically modified. Cancer Res., 53: 5274-5283, 1993.
22. Samejima, Y., and Meruelo, D. "Bystander killing" induces apoptosis and is inhibited by forskolin. Gene Ther., 2: 50-58, 1995.
23. Colombo, B. M., Benedetti, S., Ottolenghi, S., Mora, M., Polio, B., Poli, G., and Finocchiaro, G. The "bystander effect": association of U-87 cell death with ganciclovir-mediated apoptosis of nearby cells and lack of effect in athymic mice. Hum. Gene Ther., 6: 763-772, 1995.
24. Beider, D. R., Tewari, M., Friesen, P. D., Poirier, G., and Dixit, V. M. The baculovirus p35 protein inhibits Fas-and tumor necrosis factor-induced apoptosis. J. Biol. Chem., 270: 16526-16528, 1995.
25. Bi, W. L., Parysek, L. M., Warnick, R., and Stambrook, P. J. In vitro evidence that metabolic cooperation is responsible for the bystander effect observed with HSV tk retroviral gene therapy. Hum. Gene Ther., 4: 725-731, 1993.
26. Gagandeep, S., Brew, R., Green, B., Christmas, S. E., Klatzmann, D., Poston, G. J., and Kinsella, A. R. Prodrug-activated gene therapy: involvement of an immunological component in the "bystander effect." Cancer Gene Ther., 3: 83-88, 1996.
27. Caruso, M., Panis, Y., Gagandeep, S., Houssin, D., Salzmann, J. L., and Klatzmann, D. Regression of established macroscopic liver metastases after in situ transduction of a suicide gene. Proc. Natl. Acad. Sci. USA, 90: 7024-7028, 1993.
28. Mullen, C. A., Kilstrup, M., and Blaese, R. M. Transfer of the bacterial gene for cytosine deaminase to mammalian cells confers lethal sensitivity to 5-fluorocytosine: a negative selection system. Proc. Natl. Acad. Sci. USA, 89: 33-37, 1992.